Programmable Bio-NanoChip Technology for the Diagnosis of Cardiovascular Disease at the Point of Care
Nicolaos Christodoulides(Rice University), John T. McDevitt(New York University), Rachna Muldoon(Rice University), David Wampler(The University of Texas at San Antonio Health Science Center), Biykem Bozkurt(Baylor College of Medicine), Kyle Hocquard(Rice University), Chih‐Ko Yeh(The University of Texas at San Antonio Health Science Center), Ximena Sánchez(The University of Texas Medical Branch at Galveston), Aaron Patton(Rice University), Christie M. Ballantyne(Baylor College of Medicine), Wieslaw B. Furmaga(Bexar County Medical Examiner's Office), Luanyi Li(Rice University), Craig S. Miller(University of Kentucky), Pierre N. Floriano(Rice University), Spencer W. Redding(The University of Texas at San Antonio Health Science Center), Jeffrey L. Ebersole(University of Nevada, Las Vegas)
Cited by 44
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k